Diasol, Inc FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection OAI · Aug 19, 2025
  • Last warning letter 2026
Inspections 13 6 OAI
Recalls 8 0 Class I (0%)
Warning letters 4 Latest Jan 29, 2026
510(k) clearances 10 Latest Feb 10, 2014

Diasol, Inc has 8 FDA recalls, 13 inspections, 10 510(k) clearances and 4 compliance actions on record. FDA has issued 4 warning letters to Diasol, Inc, the most recent on Jan 29, 2026.

What these totals cover: FDA records filed under the name "Diasol, Inc" and its spelling variant "Diasol".

Latest recall
Z-0992-2026 · Class II · Nov 5, 2025
Latest inspection
Aug 19, 2025 · OAI
Latest 510(k)
Feb 10, 2014

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls8Nov 11, 2026 (checked Nov 15, 2026, unchanged)File dated Nov 10, 2026Current
510(k) clearances10Nov 15, 2026File dated Nov 9, 2026Current
Inspections13Nov 16, 2026Newest record Nov 5, 2026Current
Compliance actions4Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Diasol, Inc's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Diasol, Inc: FDA inspections per year

2017: 3 inspections (2 OAI), 2 warning letters, 0 recall records (0 Class I) 2018: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2019: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2020: 0 inspections (0 OAI), 0 warning letters, 1 recall record (0 Class I) 2021: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2022: 0 inspections (0 OAI), 0 warning letters, 1 recall record (0 Class I) 2023: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2024: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2025: 1 inspection (1 OAI), 0 warning letters, 6 recall records (0 Class I) 2026: 0 inspections (0 OAI), 1 warning letter, 0 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202600100
202511060
202410000
202300000
202200010
202110000
202000010
201900000
201800000
201732200

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Diasol, Inc as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Diasol, Inc yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Diasol, Inc FDA Warning Letters

4 warning letters from Aug 9, 2010 to Jan 29, 2026.

IssuedSubjectIssuing officeClose-out letter
Jan 29, 2026 · Letter on fda.gov Investigational Device Exemptions (IDE)/Premarket Approval Application (PMA)Center for Devices and Radiological Health
Sep 28, 2017 · Record page
Sep 25, 2017 · Record page
Aug 9, 2010 · Record page

A warning letter is FDA's formal notice that a company has violated FDA requirements. Each date links to the letter on fda.gov where FDA has it online. Search the text of every letter with the FDA warning letter search.

Recent recalls

8 recall records from Apr 30, 2020 to Nov 5, 2025.

NumberClassProductDate
Z-0992-2026Class IIBrand Name: Diasol Product Name: 100425-10-DEX100, Liquid Concentrate for Bicarbonate Dialysis Non…Nov 5, 2025
Z-0991-2026Class IIBrand Name: Diasol Product Name: 100325-10-DEX100, Liquid Concentrate for Bicarbonate Dialysis Non…Nov 5, 2025
Z-0989-2026Class IIBrand Name: Diasol Product Name: 100220-10-DEX100, Liquid Concentrate for Bicarbonate Dialysis Non…Nov 5, 2025
Z-0987-2026Class IIBrand Name: Diasol Product Name: 100225-10-DEX100, Liquid Concentrate for Bicarbonate Dialysis Non…Nov 5, 2025
Z-0990-2026Class IIBrand Name: Diasol Product Name: 100230-10-DEX100, Liquid Concentrate for Bicarbonate Dialysis Non…Nov 5, 2025
Z-0988-2026Class IIBrand Name: Diasol Product Name: 100125-10-DEX100, Liquid Concentrate for Bicarbonate Dialysis Non…Nov 5, 2025
Z-0207-2025Class IIDiasol Acid Concentrate REF G100325-10Dex 100Jul 27, 2022
Z-2402-2020Class IIDIASOL 1000225-10-DEX100 LIQUID ACID CONCENTRATE FOR BICARBONATE DIALYSISApr 30, 2020

Recent FDA inspections

13 inspections from Apr 3, 2009 to Aug 19, 2025.

DateSiteProductClassificationFEI
Aug 19, 2025Phoenix, AZDevicesOfficial Action Indicated (OAI)3007137482
Feb 28, 2024Phoenix, AZDevicesVoluntary Action Indicated (VAI)3007137482
Jun 28, 2021Phoenix, AZDevicesVoluntary Action Indicated (VAI)3007137482
Jun 21, 2017Phoenix, AZDevicesOfficial Action Indicated (OAI)3007137482
Jun 15, 2017Phillipsburg, NJDevicesOfficial Action Indicated (OAI)3009491770
Feb 8, 2017Phoenix, AZDevicesNo Action Indicated (NAI)3007137482
Aug 3, 2015Phoenix, AZDevicesVoluntary Action Indicated (VAI)3007137482
Apr 18, 2013Phoenix, AZDevicesNo Action Indicated (NAI)3007137482
Oct 29, 2012Phoenix, AZDevicesNo Action Indicated (NAI)3007137482
Feb 28, 2011Phoenix, AZDevicesOfficial Action Indicated (OAI)3007137482
May 28, 2010Phoenix, AZDevicesOfficial Action Indicated (OAI)3007137482
Feb 3, 2010Phoenix, AZDevicesOfficial Action Indicated (OAI)3007137482
Apr 3, 2009Phoenix, AZDevicesVoluntary Action Indicated (VAI)3007137482
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

Compliance Actions

FDA's compliance actions data lists 4 compliance actions under Diasol, Inc: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.

Most recent: Warning Letter, Jan 30, 2026.

The warning letters in this data are listed above, together with the letters FDA posts online; a letter found in both is shown once. Other actions are not listed on this page. Search them with the FDA warning letter search or browse all compliance actions.

FDA-inspected facilities

2 inspected sites, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3007137482Phoenix, AZ12Aug 19, 2025
FEI 3009491770Phillipsburg, NJ1Jun 15, 2017

Recent 510(k) clearances

10 510(k) clearances from Oct 22, 1999 to Feb 10, 2014.

K-NumberDeviceDate
K130511CITRISOL ACID CONCENTRATEFeb 10, 2014
K020231DIASOL-ADDITIVESOct 21, 2002
K020230DIASOL-BICARBApr 23, 2002
K011004NEEDLELOK HYPODERMIC NEEDLE PROTECTIONMay 24, 2001
K010958FISTULOK FISTULA NEEDLE PROTECTIONMay 18, 2001
K011003SAFESTING AND SAFESTING HUBApr 20, 2001
K993187SHELLY PROTECTED AV FISTULA NEEDLENov 5, 1999
K992999DAISY PROTECTED SCALP VEIN SETNov 5, 1999
K992653SHELLY PROTECTED AV FISTULA NEEDLEOct 27, 1999
K993212DRYASOL ACID CONCENTRATE MIXOct 22, 1999

Diasol, Inc and the FDA: common questions

Has Diasol, Inc received an FDA warning letter?

Yes. FDA has issued 4 warning letters to Diasol, Inc. The most recent is dated Jan 29, 2026, with the subject "Investigational Device Exemptions (IDE)/Premarket Approval Application (PMA)".

Has Diasol, Inc received an FDA Form 483?

FDA has not published a Form 483 for "Diasol, Inc" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Diasol, Inc?

The most recent FDA inspection on file ended Aug 19, 2025 at Phoenix, AZ and was classified OAI. FDA has 13 inspections of Diasol, Inc on file, 6 of them classified OAI (official action indicated).

Has Diasol, Inc had an FDA recall?

Yes. Diasol, Inc has 8 FDA recalls on record. The most recent started Nov 5, 2025.

Need more than this page shows? Ask about Diasol, Inc in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.